Access our full collection of sustainable healthcare resources, such as toolkits, case studies, publications and more. You can also add new resources to the library.
ABSTRACTGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as game-changers across the cardiovascular–kidney–metabolic (CKM) spectrum: overweight/obesity, type 2 diabetes mellitus…
A really interesting paper from the Centre of Evidence Based Dermatology in Nottingham. In this project they calculated the carbon footprint of the Eczema Bathing Study, a fully remote eczema trial,…
Published date
February 2026
•
by
Vaibhav Chaganti, Emma L Campbell, Jessica Griffiths, Amanda Roberts, Lisa Fox and Kim S Thomas on behalf of the Rapid Eczema Trials team
AbstractThe burden of chronic kidney disease (CKD) and its risk factors are projected to rise in parallel with the rapidly ageing global population. By 2050, the prevalence of CKD category G3–G5 may…
Published date
July 2024
•
by
Chesnaye, NC., Ortiz, A., Zoccali, C., Stel, VS., Jager, KJ.
BackgroundHaemodialysis (HD) contributes vastly to greenhouse gas (GHG) emissions. Recognizing this, the German Society for Nephrology initiated a web-based carbon footprint assessment tool to…
Published date
January 2026
•
by
Beige, J., Knöller, S., Pachmann, M., Sommer, F., Barth, HP., Masanneck, M., Kleophas, W., Schaffron, R., Stracke, S., DeGroot, K., Weinmann-Menke, J., Boedecker-Lips, SC., and Vanholder, R.
Despite the availability of kidney replacement therapy (KRT), chronic kidney disease (CKD) is among the fastest increasing global causes of premature death. Longer life expectancy and population aging…
CSH Kidney Care Sustainability Network January Event.About the speaker: Dr Tamara Glavinovic – Nephrologist, University of OttawaDr Glavinovic is a nephrologist with a clinical focus on reproductive…
Sex (biologically determined) and gender (socially constructed) modulate manifestations and prognosis of a vast number of diseases, including cardiovascular disease (CVD) and chronic kidney disease…
Published date
February 2024
•
by
Balafa, O., Fernandez-Fernandez, B., Ortiz, A., Dounousi, E., Ekart, R., Ferro, CJ., Mark, PB., Valdivielso, JM., Del Vecchio, L., Mallamaci, F.
Hemodialysis is a life-sustaining treatment for patients with end-stage renal disease, but it is notoriously resource-intensive, requiring vast quantities of high-purity water. This significant water…
Diabetes is the most common cause of chronic kidney disease (CKD), a condition found in 850 million persons and projected to become the fifth global cause of death by 2040. Research is needed that…
Purpose of reviewThe 2023 CONVINCE trial demonstrated improved survival with high-dose hemodiafiltration (HDF), prompting discussions about widespread adoption. However, this clinical advancement…
